Hydroxychloroquine Withdrawal of the article that has no effect on corona treatment June 5 9:19
A study group announced last month that the effect of the treatment was not confirmed for the therapeutic drug for malaria, etc., which is being clinically tested worldwide, whether it is effective for the treatment of new coronavirus, data He said he withdrew his thesis, saying he could not confirm the truthfulness of.
Research groups in the United States and Switzerland have analyzed the data of approximately 96,000 patients regarding "hydroxychloroquine" and "chloroquine", which are known as therapeutic agents for malaria, and as a result, about the treatment of the new coronavirus, " "No effect was observed" was published last month in the British medical journal Lancet.
However, because the research group was pointed out that there was a problem with the data used in the analysis, they asked an external expert to perform the verification.
According to the study group, experts asked the company that provided the patient's data to publish the entire data, but it was denied because it was against the agreement with the data provider.
For this reason, three researchers in the research group announced that they would withdraw this paper, saying they could not confirm the truth of the data.
According to the editorial department of Lancet, the company that provided the data for this study is also involved in several other studies.
Among the studies, "ivermectin", which was developed based on a substance discovered by Prof. Satoshi Omura of Kitasato University who won the Nobel Prize in Medicine and Physiology in 2015, was used to determine the mortality rate of patients with new coronavirus. "Lancet" "needs an international investigation into the veracity of these data," including a study from an American university that reported lowering.